CN Patent

CN107207559B — 作为制备类固醇fxr调节剂的中间体的6-烷基-7-羟基-4-烯-3-酮类固醇

Assigned to Nzp Uk Ltd · Expires 2019-10-25 · 7y expired

What this patent protects

本发明涉及式(I)化合物，其中R 1 、R 2 、Y、R 4 和R 5 如本文定义。该化合物是合成的胆汁酸合成时的中间体。

USPTO Abstract

本发明涉及式(I)化合物，其中R 1 、R 2 、Y、R 4 和R 5 如本文定义。该化合物是合成的胆汁酸合成时的中间体。

Drugs covered by this patent

Patent Metadata

Patent number
CN107207559B
Jurisdiction
CN
Classification
—
Expires
2019-10-25
Drug substance claim
No
Drug product claim
No
Assignee
Nzp Uk Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.